Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Statin Stories

2013-05-21 12:27:32

ISTANBUL, May 21, 2013 /PRNewswire/ -- The congress of the ERA-EDTA (European Renal Association - European Dialysis and Transplant Association) is the biggest congress in Europe on nephrology and renal replacement therapy. Nearly 10,000 participants are in Istanbul to share their knowledge and discuss the latest research findings. New pioneering studies have been presented: / (1) Gupta, A et al. "SOLUBLE FERRIC PYROPHOSPHATE (SFP) ADMINISTERED VIA HEMODIALYSATE REDUCES...

2013-05-14 08:33:51

Non-white patients have 50 percent greater odds, women have 10 percent greater odds of being non-adherent to statin medications for treatment of high cholesterol WOONSOCKET, R.I., May 14, 2013 /PRNewswire/ -- High cholesterol is one of the major risk factors for coronary heart disease, heart attack and stroke,[1] which can be well managed with available prescription medications. New research sheds light onto the impact of gender and race on medication adherence for statins used to...

2013-05-13 16:27:05

Largest study of LDL blood levels, based on tests of nearly 105 million Americans, suggests improvements in cardiovascular health may have stalled in recent years MADISON, N.J., May 13, 2013 /PRNewswire/ -- Decades of declines in LDL cholesterol blood levels, a key marker of death risk from heart disease, abruptly ended in 2008, and may have stalled since, according to a multi-year, national study published in PLOS ONE. The study, by researchers at Quest Diagnostics (NYSE: DGX),...

2013-05-09 23:01:44

The firm is currently offering Lipitor lawsuit evaluations to those who have suffered from allegedly serious Lipitor side effects. (PRWEB) May 09, 2013 For the first time in 55 years, spending on medications in the United States has dropped, in part because of patent expirations for popular drugs such as Lipitor.* The Rottenstein Law Group LLP, a Lipitor law firm, offers its opinion on what this means for those who seek to file Lipitor lawsuits because they suffered from Lipitor-induced...

Cholesterol Drug Liptruzet Approved By The FDA
2013-05-06 06:05:53

redOrbit Staff & Wire Reports - Your Universe Online Liptruzet, a combination drug developed by Merck that has been found to lower a patient´s low-density lipoprotein (LDL) cholesterol levels, has been approved by the US Food and Drug Administration (FDA). According to MedPage Today Cardiology Editor Chris Kaiser, Liptruzet is a combination of the drugs ezetimibe and atorvastatin and has been approved for the treatment of hyperlipidemia, a condition characterized by abnormally...

2013-04-23 16:25:26

Researchers found reasons for not picking up initial cholesterol-lowering medications include perceived concerns and a decision to try lifestyle modifications PASADENA, Calif., April 23, 2013 /PRNewswire/ -- Patients who do not fill their first prescription for cholesterol-lowering statins give a wide range of reasons for not doing so, including perceived concerns about the medication, a fear of side-effects and a decision to try lifestyle modifications instead of prescription...

2013-04-18 08:30:20

IVUS data will evaluate plaque regression in patients with high-risk Cardiovascular Disease TSX Exchange Symbol: RVX CALGARY, April 18, 2013 /PRNewswire/ - Resverlogix Corp. (TSX:RVX) today announced that it has completed dosing in ASSURE, a Phase 2b clinical trial evaluating RVX-208, Resverlogix's first-in-class orally active BET-protein inhibitor, using intra-vascular ultrasound (IVUS) in high-risk cardiovascular patients with low HDL and ApoA-I (n=324). These target patients...

Researchers Discover New Way To Cleanse The Blood Of Cholesterol
2013-04-11 07:22:17

redOrbit Staff & Wire Reports - Your Universe Online Researchers from the University of Michigan (UMich) have found a new genetic target which they believe could be used instead of -- or along with -- statins to help lower a person´s cholesterol. Scientists working in the lab of David Ginsburg at the Ann Arbor-based university´s Life Sciences Institute managed to inhibit the action of a gene responsible for transporting a protein known to interfere with the liver´s...

2013-04-03 08:29:05

Previous studies showed higher costs of care for patient adherence to brand-name statins; new study shows generic statin adherence can lower overall costs SAN DIEGO, April 3, 2013 /PRNewswire/ -- People who regularly take statins to reduce high cholesterol will see lower hospitalization rates according to a new study presented today at the Academy of Managed Care Pharmacy (AMCP)'s 25th Annual Meeting & Expo in San Diego. The study was conducted by pharmacy benefit manager Prime...

2013-03-25 16:25:03

OXFORD, England, March 25, 2013 /PRNewswire/ -- Senior researchers at Oxford University's Clinical Trial Service Unit welcomed today's statement by the Principal Investigators of the AIM-HIGH trial about the consistency of the adverse effects seen in the AIM-HIGH trial of extended-release niacin (Niaspan) with those reported from the HPS2-THRIVE trial of extended-release niacin given in combination with laropiprant (Tredaptive). The findings of the HPS2-THRIVE trial of...